Forward Citations = 22

Loading Chart...

3 inventors (with patents filed for the assignee):

David M White (4 out of 10 patents)

Barry G W Arnason (4 out of 5 patents)

Mark A Jensen (4 out of 5 patents)

4. Inc Iterative Therapeutics (0 patent)

4 patents: Sort by Forward Citations

1. 9127063 - Nucleic acids related to fusion proteins (2015-09-08),

2. 8986698 - Method of using fusion proteins (2015-03-24),

3. 8163289 - Methods and compositions involving polymeric immunoglobulin fusion proteins (2012-04-24),

4. 7897729 - Polymeric immunoglobulin fusion proteins that target low affinity FcγReceptors (2011-03-01),

Iterative Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative therapies for neurodegenerative diseases. With a team of experienced scientists and researchers, Iterative Therapeutics is dedicated to advancing novel treatment options to improve the lives of patients. Their cutting-edge approach combines in-depth research with state-of-the-art technology to create impactful solutions that address unmet medical needs.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

4 Patents

#636 in Chicago, IL

#2,762 in Illinois

#59,059 in US

Chicago, IL, United States of America

Iterative Therapeutics, Inc.

Forward Citations = 22

3 inventors:

David M White (4 out of 10 patents)

Barry G W Arnason (4 out of 5 patents)

Mark A Jensen (4 out of 5 patents)

4. Inc Iterative Therapeutics (0 patent)

Please report any incorrect information to support@idiyas.com